CSRA Insider Trading Activity and SEC Form 4 Filings
CSRA insider trading summary
No open-market insider purchases or sales of CSRA Inc. (CSRA) have been reported on SEC Form 4 in the past 12 months.
Latest CSRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 23, 2017 | George Batsakis | EVP, Chief Growth Officer | Sell | $892K (28,392 @ $31.42) |
| Aug 18, 2017 | John Reing | EVP, Chief HR Officer | Sell | $645.9M (20,298 @ $31822.00) |
| Aug 17, 2017 | Craig L Martin | Director | Buy | $646K (20,000 @ $32.31) |
| Jun 2, 2017 | Lawrence B Prior III | President and CEO | Buy | $1.5M (49,500 @ $30.50) |
| May 31, 2017 | David F Keffer | EVP, Chief Financial Officer | Sell | $602K (20,000 @ $30.08) |
| Mar 1, 2017 | Paul Nedzbala | EVP, Health and Civil Group | Sell | $466K (15,336 @ $30.38) |
| Feb 23, 2017 | George Batsakis | EVP, Chief Growth Officer | Sell | $97K (3,200 @ $30.32) |
| Feb 23, 2017 | George Batsakis | EVP, Chief Growth Officer | Sell | $3K (100 @ $30.31) |
| Feb 23, 2017 | George Batsakis | EVP, Chief Growth Officer | Sell | $6K (200 @ $30.30) |
| Feb 23, 2017 | George Batsakis | EVP, Chief Growth Officer | Sell | $45K (1,500 @ $30.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.